Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vera-Til SR 120mg tablets (Tillomed)
0206020T0BMAAAU
|
Vera-Til | Verapamil hydrochloride | Cardiovascular System | 4,209 |
|
Diltiazem 200mg modified-release capsules
0206020C0AAAXAX
|
Diltiazem hydrochloride | Diltiazem hydrochloride | Cardiovascular System | 4,205 |
|
Diltiazem 90mg modified-release tablets
0206020C0AAACAC
|
Diltiazem hydrochloride | Diltiazem hydrochloride | Cardiovascular System | 4,205 |
|
Tapentadol 150mg modified-release tablets
0407020AGAAAEAE
|
Tapentadol | Tapentadol | Central Nervous System | 4,204 |
|
Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets
0205052R0AAABAB
|
Telmisartan/hydrochlorothiazide | Telmisartan with diuretic | Cardiovascular System | 4,202 |
|
Ursodeoxycholic acid 250mg/5ml oral suspension sugar free
0109010U0AABEBE
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 4,192 |
|
Diphenhydramine 50mg tablets
0304010N0AAAPAP
|
Diphenhydramine hydrochloride (Antihistamine) | Diphenhydramine hydrochloride | Respiratory System | 4,189 |
|
VitA-POS eye ointment preservative free
21300000710
|
VitA-POS eye ointment preservative free | Eye Products | Appliances | 4,189 |
|
Terazosin 2mg tablets
0205040V0AAABAB
|
Terazosin hydrochloride (Antihypertensive) | Terazosin hydrochloride | Cardiovascular System | 4,179 |
|
Cutimed Sorbact Contact swab 4cm x 6cm
20040200643
|
Cutimed Sorbact Contact swab 4cm x 6cm | Gauzes & Gauze Tissue | Dressings | 4,178 |
|
Doublebase emollient wash gel
130201000BBMGCA
|
Proprietary compound emollients | Other emollient preparations | Skin | 4,177 |
|
Ropinirole 6mg modified-release tablets
0409010H0AAASAS
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | 4,176 |
|
Softpore dressing 10cm x 15cm
20030100372
|
Softpore dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | 4,175 |
|
Enoxaparin sodium 40mg/0.4ml inj pre-filled syringes
0208010D0AAABAB
|
Enoxaparin | Enoxaparin | Cardiovascular System | 4,172 |
|
Chloramphenicol 0.5% eye drops preservative free
1103010C0AAAJAJ
|
Chloramphenicol (Eye) | Chloramphenicol | Eye | 4,170 |
|
Uvistat sun cream SPF 50
130801000BBKNA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 4,170 |
|
KerraMaxCare dressing 20cm x 22cm rectangular
20031700168
|
KerraMaxCare dressing 20cm x 22cm rectangular | Wound Management & Other Dressings | Dressings | 4,155 |
|
Digoxin 50micrograms/ml oral solution
0201010F0AAAAAA
|
Digoxin | Digoxin | Cardiovascular System | 4,151 |
|
Abasaglar 100units/ml solution for injection 3ml cartridges
0601012V0BDABAA
|
Abasaglar | Insulin glargine | Endocrine System | 4,143 |
|
Biatain Silicone dressing 12.5cm x 12.5cm
20030900240
|
Biatain Silicone dressing 12.5cm x 12.5cm | Wound Management & Other Dressings | Dressings | 4,142 |
|
Confidence BE ileostomy bag with filter and overlap, standard 13-55mm black
23604106514
|
Confidence BE ileostomy bag with filter and overlap, standard 13-55mm black | Ileostomy Bags | Stoma Appliances | 4,140 |
|
Morphine 60mg modified-release capsules
0407020Q0AAEHEH
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 4,140 |
|
Phenazone 40mg/g / Lidocaine 10mg/g ear drops
1201010AGAAAAAA
|
Phenazone/lidocaine | Phenazone/lidocaine | Ear, Nose and Oropharynx | 4,139 |
|
Prosys all silicone open ended catheter male 12Ch-18Ch
21020001560
|
Prosys all silicone open ended catheter male 12Ch-18Ch | Catheters | Appliances | 4,137 |
|
Metoject PEN 12.5mg/0.25ml inj pre-filled pens
1001030U0BEAYCD
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 4,123 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.